Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Liver Diseases

Free Subscription 02.02.2026 1 Am J Gastroenterol 1 Biochem Biophys Res Commun 2 BMC Cancer 1 BMC Gastroenterol 1 Dig Dis Sci 2 Endoscopy 2 Gastroenterology 1 Gastrointest Endosc 2 Hepatology 4 J Hepatol 2 J Pediatr Surg 1 Oncogene 1 PLoS One 2 Radiology 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. SHABBIR R, Garrido-Trevino L, O'Leary JG, Chaudhary A, et al
   MELD-Lactate and lactate clearance in critically ill cirrhosis patients with sepsis.
   Am J Gastroenterol. 2026 Jan 27. doi: 10.14309/ajg.0000000000003934.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. WU J, Chen C, Hu X, Cai X, et al
   Corrigendum to "Suppressing Cyclooxygenase-2 Prevents nonalcoholic and inhibits apoptosis of hepatocytes that are involved in the Akt/p53 signal pathway" [Biochem. Biophys. Res. Commun. 469 (2016) 1034-1040].
   Biochem Biophys Res Commun. 2026 Jan 27:153299. doi: 10.1016/j.bbrc.2026.153299.
   PubMed        
   
   

   
   BMC Cancer

3. ZHANG W, Mao X, Lu X, Yu X, et al
   Nanoparticles based on photothermal effects in the treatment of hepatocellular carcinoma (HCC): a meta-analysis and systematic review.
   BMC Cancer. 2026 Jan 29. doi: 10.1186/s12885-026-15575.
   PubMed         Abstract available
   
   
4. ROY D, Guckelberger O, Oppermann E, Budeyri I, et al
   Longitudinal monitoring of circulating tumor cell dynamics for potential prediction of early recurrence and clinical outcomes after curative resection of hepatocellular carcinoma: a pilot study.
   BMC Cancer. 2026 Jan 29. doi: 10.1186/s12885-026-15638.
   PubMed        
   
   

   
   BMC Gastroenterol

5. ULUSAN M, Yildiz M, Erdogan MA, Simsek O, et al
   Therapeutic potential of beta-sitosterol in methotrexate-induced liver injury: association with STING and ERK-1 pathways.
   BMC Gastroenterol. 2026;26:75.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

6. ROSE S, Ashraf MU, Shastri A, Priya K, et al
   Rifaximin Improves Frailty in Patients with Decompensated Cirrhosis: A Randomized Trial.
   Dig Dis Sci. 2026 Jan 24. doi: 10.1007/s10620-025-09660.
   PubMed         Abstract available
   
   

   
   Endoscopy

7. WANG Z, Mei X, Bai Y, Zhang Q, et al
   Endoscopic ultrasound-guided perforator-targeted embolization for gastric variceal bleeding due to left-sided portal hypertension.
   Endoscopy. 2026;58.
   PubMed        
   
   
8. KURIHARA K, Isayama H, Matsuzaki A, Hakuta R, et al
   Endoscopic ultrasonography-guided B3 branch drainage/anastomosis as hepaticoduodenostomy in atrophic left hepatic lobe case.
   Endoscopy. 2026;58.
   PubMed        
   
   

   
   Gastroenterology

9. ACEITUNO L, Banares J, Pons M, Rivera-Esteban J, et al
   The ANTICIPATE-NASH Models Stratify Better the Risk of Clinical Events Than Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients With Advanced Chronic Liver Disease.
   Gastroenterology. 2026;170:385-394.
   PubMed         Abstract available
   
   
10. LEE TH, Duong N, Simonetto DA, Paul S, et al
    Knowledge, Attitudes, and Environment Related to Gastroenterology and Hepatology Care for Sexual and Gender Minorities.
    Gastroenterology. 2026;170:246-251.
    PubMed        
    
    

    
    Gastrointest Endosc

11. MESQUITA P, Pinho R, Costa C, Louro H, et al
    Non-Confluent Hepatic Ducts Draining Separately into the Duodenum: A Unique Biliary Tree Variant.
    Gastrointest Endosc. 2026 Jan 22:S0016-5107(26)00046.
    PubMed        
    
    

    
    Hepatology

12. YAMAZOE T, Kakazu E, Matsuda M, Mino M, et al
    Genomic and transcriptomic profiling of hepatocellular carcinoma in patients with Fontan-associated liver disease.
    Hepatology. 2026 Jan 26. doi: 10.1097/HEP.0000000000001693.
    PubMed         Abstract available
    
    
13. YANG J, Hwang Y, Ju JS, Han S, et al
    Impact of newer antihyperglycemic agents on hepatic complications: A systematic review and meta-analysis of data from 5.3 million patients with type 2 diabetes mellitus.
    Hepatology. 2026 Jan 29. doi: 10.1097/HEP.0000000000001695.
    PubMed         Abstract available
    
    

    
    J Hepatol

14. SHEN YC, Pinato DJ, Liu TH, Lu LC, et al
    Revisiting Prophylactic Corticosteroids to Mitigate Severe Immune-Related Adverse Events in Hepatocellular Carcinoma.
    J Hepatol. 2026 Jan 23:S0168-8278(26)00021-8. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
15. YOPP A, Chen M, Cheng AL, Kaseb A, et al
    Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma.
    J Hepatol. 2026 Jan 22:S0168-8278(26)00017-6. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
16. KIM NG, Yao FY, Kwong AJ, Mehta N, et al
    Yttrium-90 radioembolization is associated with a lower risk of liver transplant waitlist dropout than chemoembolization in hepatocellular carcinoma.
    J Hepatol. 2026 Jan 22:S0168-8278(26)00020-6. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
17. HOFER BS, Tonon M, Buttler L, Camoes Neves J, et al
    Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.
    J Hepatol. 2026 Jan 22:S0168-8278(26)00018-8. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    

    
    J Pediatr Surg

18. ZHANG X, Feng J, Wen Y, Shi K, et al
    Clinical characteristics, treatment, and prognosis of undifferentiated embryonal sarcoma of the liver in children: A retrospective study from four hospitals in China.
    J Pediatr Surg. 2026;61:162819.
    PubMed         Abstract available
    
    
19. LING KUM VT, Yeung F, Yu Chung PH, Yuen Wong KK, et al
    Cholangitis is associated with liver fibrosis in choledochal malformations.
    J Pediatr Surg. 2025 Aug 7:162502. doi: 10.1016/j.jpedsurg.2025.162502.
    PubMed         Abstract available
    
    

    
    Oncogene

20. TAYA M, Fishman D, Kanani F, Zinger L, et al
    The role of the SLC25A15 transporter in the formation of liver metastasis in ESR1-mutated breast cancer.
    Oncogene. 2026 Jan 3. doi: 10.1038/s41388-025-03640.
    PubMed         Abstract available
    
    

    
    PLoS One

21. ZHAO Y, Wang Z, Liu Y, Yang T, et al
    Association between uric acid and non-alcoholic fatty liver disease in patients with hypertension.
    PLoS One. 2026;21:e0341949.
    PubMed         Abstract available
    
    

    
    Radiology

22. DAGGUMATI L, Stark L, Booth AL, Fraum TJ, et al
    Case 344: Hepatic Epithelioid Hemangioendothelioma.
    Radiology. 2026;318:e251815.
    PubMed         Abstract available
    
    
23. MATTEINI F, Vilgrain V
    Isolated Hepatic Mucormycosis in Acute Lymphoblastic Leukemia.
    Radiology. 2026;318:e252306.
    PubMed        
    
    

    
    Transplantation

24. MARTINEZ-ARENAS L, Carvalho-Gomes A, Vidal E, Brandman D, et al
    The Relentless Progression of Metabolic Dysfunction-associated Steatotic Liver Disease in Liver Transplantation in Spain.
    Transplantation. 2025 Oct 31. doi: 10.1097/TP.0000000000005554.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum